This trial tests a digital intervention to reduce depression and rumination in individuals with elevated symptoms. Participants use the intervention for 4 weeks & complete daily & weekly surveys.
1 Primary · 3 Secondary · Reporting Duration: daily over 4 weeks
2 Treatment Groups
Gamified Attention Bias Modification
1 of 2
Gamified Placebo Training
1 of 2
100 Total Participants · 2 Treatment Groups
Primary Treatment: Gamified Attention Bias Modification · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 45 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there still an opportunity to join this research endeavor?
"Per clinicaltrials.gov, this medical trial has ceased accepting participants - the initial posting of which was on September 1st 2023 and its last update occurring in November 30th 2022. At present, there are 1290 other trials available that require recruitment of patients." - Anonymous Online Contributor
Who has the potential to partake in this research endeavor?
"This medical trial is seeking to enrol 100 individuals with depressive symptoms aged between 18-45. To be considered, applicants must have normal or corrected vision; proficient English language skills; PHQ-8 rating of 10+; an attention bias task score higher than 6500 ms on sad faces; remain stable on any psychiatric and neurological medication they are taking; access to a smartphone for downloading the app and a laptop/desktop device to complete weekly assessments. These criteria should all be met in order for potential participants to provide informed consent." - Anonymous Online Contributor
Are individuals over 40 years of age being considered for this trial?
"As per the trial requirements, only adults between 18 and 45 are eligible to participate." - Anonymous Online Contributor